{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T02:46:04Z","timestamp":1778813164821,"version":"3.51.4"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,11]],"date-time":"2024-11-11T00:00:00Z","timestamp":1731283200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,11,11]],"date-time":"2024-11-11T00:00:00Z","timestamp":1731283200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-78751-2","type":"journal-article","created":{"date-parts":[[2024,11,11]],"date-time":"2024-11-11T15:47:32Z","timestamp":1731340052000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Primate-specific 82-kDa choline acetyltransferase attenuates progression of Alzheimer\u2019s disease-like pathology in the APPNL-G-F knock-in mouse model"],"prefix":"10.1038","volume":"14","author":[{"given":"Hadir E.","family":"AlQot","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca Jane","family":"Rylett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,11,11]]},"reference":[{"key":"78751_CR1","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s004060050027","volume":"248","author":"HJ M\u00f6ller","year":"1998","unstructured":"M\u00f6ller, H. J. & Graeber, M. B. The case described by Alois Alzheimer in 1911. Historical and conceptual perspectives based on the clinical record and neurohistological sections. Eur. Arch. Psychiatry Clin. NeuroSci. 248, 111\u2013122. https:\/\/doi.org\/10.1007\/s004060050027 (1998).","journal-title":"Eur. Arch. Psychiatry Clin. NeuroSci."},{"key":"78751_CR2","doi-asserted-by":"publisher","first-page":"101580","DOI":"10.1016\/j.eclinm.2022.101580","volume":"51","author":"A Nandi","year":"2022","unstructured":"Nandi, A. et al. Global and regional projections of the economic burden of Alzheimer\u2019s disease and related dementias from 2019 to 2050: a value of statistical life approach. EClinicalMedicine 51, 101580. https:\/\/doi.org\/10.1016\/j.eclinm.2022.101580 (2022).","journal-title":"EClinicalMedicine"},{"key":"78751_CR3","doi-asserted-by":"publisher","first-page":"937486","DOI":"10.3389\/fnagi.2022.937486","volume":"14","author":"X Li","year":"2022","unstructured":"Li, X. et al. Global, regional, and national burden of Alzheimer\u2019s disease and other dementias, 1990\u20132019. Front. Aging Neurosci. 14, 937486. https:\/\/doi.org\/10.3389\/fnagi.2022.937486 (2022).","journal-title":"Front. Aging Neurosci."},{"key":"78751_CR4","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/978-3-7091-6467-9_15","volume":"53","author":"K Iqbal","year":"1998","unstructured":"Iqbal, K. et al. Mechanisms of neurofibrillary degeneration and the formation of neurofibrillary tangles. J. Neural Transm. 53, 169\u2013180. https:\/\/doi.org\/10.1007\/978-3-7091-6467-9_15 (1998).","journal-title":"J. Neural Transm."},{"issue":"1\u20132","key":"78751_CR5","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1385\/JMN:23:1-2:105","volume":"23","author":"R Vassar","year":"2004","unstructured":"Vassar, R. BACE1: the beta-secretase enzyme in Alzheimer\u2019s disease. J. Mol. Neurosci. 23(1\u20132), 105\u2013114. https:\/\/doi.org\/10.1385\/JMN:23:1-2:105 (2004).","journal-title":"J. Mol. Neurosci."},{"key":"78751_CR6","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/s41392-019-0063-8","volume":"4","author":"PP Liu","year":"2019","unstructured":"Liu, P. P., Xie, Y., Meng, X. Y. & Kang, J. S. History and progress of hypotheses and clinical trials for Alzheimer\u2019s disease. Signal. Transduct. Target. Ther. 4, 29. https:\/\/doi.org\/10.1038\/s41392-019-0063-8 (2019).","journal-title":"Signal. Transduct. Target. Ther."},{"key":"78751_CR7","doi-asserted-by":"publisher","first-page":"160","DOI":"10.3389\/fnagi.2016.00160","volume":"8","author":"M Ries","year":"2016","unstructured":"Ries, M. & Sastre, M. Mechanisms of A\u03b2 clearance and degradation by glial cells. Front. Aging Neurosci. 8, 160. https:\/\/doi.org\/10.3389\/fnagi.2016.00160 (2016).","journal-title":"Front. Aging Neurosci."},{"issue":"6","key":"78751_CR8","doi-asserted-by":"publisher","first-page":"a006379","DOI":"10.1101\/cshperspect.a006379","volume":"2","author":"T Saido","year":"2012","unstructured":"Saido, T. & Leissring, M. A. Proteolytic degradation of amyloid \u03b2-protein. Cold Spring Harbor Perspect. Med. 2(6), a006379. https:\/\/doi.org\/10.1101\/cshperspect.a006379 (2012).","journal-title":"Cold Spring Harbor Perspect. Med."},{"issue":"12","key":"78751_CR9","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1038\/nrn3114","volume":"12","author":"BV Zlokovic","year":"2011","unstructured":"Zlokovic, B. V. Neurovascular pathways to neurodegeneration in Alzheimer\u2019s disease and other disorders. Nat. Rev. Neurosci. 12(12), 723\u2013738. https:\/\/doi.org\/10.1038\/nrn3114 (2011).","journal-title":"Nat. Rev. Neurosci."},{"key":"78751_CR10","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.nbd.2014.07.012","volume":"71","author":"M Pappolla","year":"2014","unstructured":"Pappolla, M. et al. Evidence for lymphatic A\u03b2 clearance in Alzheimer\u2019s transgenic mice. Neurobiol. Dis. 71, 215\u2013219. https:\/\/doi.org\/10.1016\/j.nbd.2014.07.012 (2014).","journal-title":"Neurobiol. Dis."},{"issue":"3","key":"78751_CR11","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1179\/1743132813Y.0000000288","volume":"36","author":"L Hong","year":"2014","unstructured":"Hong, L., Huang, H. C. & Jiang, Z. F. Relationship between amyloid-beta and the ubiquitin-proteasome system in Alzheimer\u2019s disease. Neurol. Res. 36(3), 276\u2013282. https:\/\/doi.org\/10.1179\/1743132813Y.0000000288 (2014).","journal-title":"Neurol. Res."},{"issue":"11","key":"78751_CR12","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1089\/dna.2014.2738","volume":"34","author":"YD Zhang","year":"2015","unstructured":"Zhang, Y. D. & Zhao, J. J. TFEB participates in the A\u03b2-induced pathogenesis of Alzheimer\u2019s disease by regulating the autophagy-lysosome pathway. DNA Cell Biol. 34(11), 661\u2013668. https:\/\/doi.org\/10.1089\/dna.2014.2738 (2015).","journal-title":"DNA Cell Biol."},{"key":"78751_CR13","doi-asserted-by":"publisher","first-page":"61","DOI":"10.3233\/JAD-2011-102139","volume":"2","author":"A Kurz","year":"2011","unstructured":"Kurz, A. & Perneczky, R. Amyloid clearance as a treatment target against Alzheimer\u2019s disease. J. Alzheimer\u2019s Dis. 24, 61\u201373. https:\/\/doi.org\/10.3233\/JAD-2011-102139 (2011).","journal-title":"J. Alzheimer\u2019s Dis."},{"issue":"Pt 2","key":"78751_CR14","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1042\/bj3480359","volume":"2","author":"T Tokuda","year":"2000","unstructured":"Tokuda, T. et al. Lipidation of apolipoprotein E influences its isoform-specific interaction with Alzheimer\u2019s amyloid beta peptides. Biochem. J. 2(Pt 2), 359\u2013365 (2000).","journal-title":"Biochem. J."},{"issue":"5","key":"78751_CR15","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/j.neuron.2008.04.010","volume":"58","author":"Q Jiang","year":"2008","unstructured":"Jiang, Q. et al. ApoE promotes the proteolytic degradation of Abeta. Neuron 58(5), 681\u2013693. https:\/\/doi.org\/10.1016\/j.neuron.2008.04.010 (2008).","journal-title":"Neuron"},{"issue":"2","key":"78751_CR16","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1189\/jlb.1203620","volume":"76","author":"V Laporte","year":"2004","unstructured":"Laporte, V. et al. Uptake of Abeta 1-40- and abeta 1-42-coated yeast by microglial cells: a role for LRP. J. Leukoc. Biol. 76(2), 451\u2013461. https:\/\/doi.org\/10.1189\/jlb.1203620 (2004).","journal-title":"J. Leukoc. Biol."},{"key":"78751_CR17","doi-asserted-by":"publisher","first-page":"2932","DOI":"10.1038\/ncomms3932","volume":"4","author":"AP Sagare","year":"2013","unstructured":"Sagare, A. P. et al. Pericyte loss influences Alzheimer-like neurodegeneration in mice. Nat. Commun. 4, 2932. https:\/\/doi.org\/10.1038\/ncomms3932 (2013).","journal-title":"Nat. Commun."},{"issue":"6","key":"78751_CR18","first-page":"427","volume":"29","author":"S Kar","year":"2004","unstructured":"Kar, S., Slowikowski, S. P., Westaway, D. & Mount, H. T. Interactions between beta-amyloid and central cholinergic neurons: implications for Alzheimer\u2019s disease. J. Psychiatry Neurosci. 29(6), 427\u2013441 (2004).","journal-title":"J. Psychiatry Neurosci."},{"issue":"51","key":"78751_CR19","doi-asserted-by":"publisher","first-page":"40180","DOI":"10.1074\/jbc.M110.142356","volume":"285","author":"K Takata","year":"2010","unstructured":"Takata, K. et al. Galantamine-induced amyloid-{beta} clearance mediated via stimulation of microglial nicotinic acetylcholine receptors. J. Biol. Chem. 285(51), 40180\u201340191. https:\/\/doi.org\/10.1074\/jbc.M110.142356 (2010).","journal-title":"J. Biol. Chem."},{"issue":"6\u20137","key":"78751_CR20","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1007\/s11064-005-6962-9","volume":"30","author":"R Schliebs","year":"2005","unstructured":"Schliebs, R. Basal forebrain cholinergic dysfunction in Alzheimer\u2019s disease\u2013interrelationship with beta-amyloid, inflammation and neurotrophin signaling. Neurochem. Res. 30(6\u20137), 895\u2013908. https:\/\/doi.org\/10.1007\/s11064-005-6962-9 (2005).","journal-title":"Neurochem. Res."},{"issue":"8","key":"78751_CR21","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1016\/j.bcp.2005.05.019","volume":"70","author":"M McKinney","year":"2005","unstructured":"McKinney, M. & Jacksonville, M. C. Brain cholinergic vulnerability: relevance to behavior and disease. Biochem. Pharmacol. 70(8), 1115\u20131124. https:\/\/doi.org\/10.1016\/j.bcp.2005.05.019 (2005).","journal-title":"Biochem. Pharmacol."},{"issue":"4","key":"78751_CR22","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1093\/jnen\/59.4.308","volume":"59","author":"TG Beach","year":"2000","unstructured":"Beach, T. G. et al. The cholinergic deficit coincides with Abeta deposition at the earliest histopathologic stages of Alzheimer disease. J. Neuropathol. Exp. Neurol. 59(4), 308\u2013313. https:\/\/doi.org\/10.1093\/jnen\/59.4.308 (2000).","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"27","key":"78751_CR23","doi-asserted-by":"publisher","first-page":"19417","DOI":"10.1074\/jbc.274.27.19417","volume":"274","author":"MC Resendes","year":"1999","unstructured":"Resendes, M. C., Dobransky, T., Ferguson, S. S. & Rylett, R. J. Nuclear localization of the 82-kDa form of human choline acetyltransferase. J. Biol. Chem. 274(27), 19417\u201319421. https:\/\/doi.org\/10.1074\/jbc.274.27.19417 (1999).","journal-title":"J. Biol. Chem."},{"issue":"7","key":"78751_CR24","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1016\/j.neurobiolaging.2006.05.011","volume":"28","author":"SK Gill","year":"2007","unstructured":"Gill, S. K. et al. 82-kDa choline acetyltransferase is in nuclei of cholinergic neurons in human CNS and altered in aging and Alzheimer disease. Neurobiol. Aging 28(7), 1028\u20131040. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2006.05.011 (2007).","journal-title":"Neurobiol. Aging"},{"key":"78751_CR25","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.nbd.2014.05.008","volume":"69","author":"S Albers","year":"2014","unstructured":"Albers, S. et al. Nuclear 82-kDa choline acetyltransferase decreases amyloidogenic APP metabolism in neurons from APP\/PS1 transgenic mice. Neurobiol. Dis. 69, 32\u201342. https:\/\/doi.org\/10.1016\/j.nbd.2014.05.008 (2014).","journal-title":"Neurobiol. Dis."},{"key":"78751_CR26","doi-asserted-by":"publisher","first-page":"23914","DOI":"10.1038\/srep23914","volume":"6","author":"W Winick-Ng","year":"2016","unstructured":"Winick-Ng, W. et al. 82-kDa choline acetyltransferase and SATB1 localize to \u03b2-amyloid induced matrix attachment regions. Sci. Rep. 6, 23914. https:\/\/doi.org\/10.1038\/srep23914 (2016).","journal-title":"Sci. Rep."},{"issue":"1","key":"78751_CR27","doi-asserted-by":"publisher","first-page":"3037","DOI":"10.1038\/s41598-023-30155-4","volume":"13","author":"HE AlQot","year":"2023","unstructured":"AlQot, H. E. & Rylett, R. J. A novel transgenic mouse model expressing primate-specific nuclear choline acetyltransferase: insights into potential cholinergic vulnerability. Sci. Rep. 13(1), 3037. https:\/\/doi.org\/10.1038\/s41598-023-30155-4 (2023).","journal-title":"Sci. Rep."},{"issue":"5","key":"78751_CR28","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1038\/nn.3697","volume":"17","author":"T Saito","year":"2014","unstructured":"Saito, T. et al. Single app knock-in mouse models of Alzheimer\u2019s disease. Nat. Neurosci. 17(5), 661\u2013663. https:\/\/doi.org\/10.1038\/nn.3697 (2014).","journal-title":"Nat. Neurosci."},{"key":"78751_CR29","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3389\/fphar.2012.00014","volume":"3","author":"E Solito","year":"2012","unstructured":"Solito, E. & Sastre, M. Microglia function in Alzheimer\u2019s disease. Front. Pharmacol. 3, 14. https:\/\/doi.org\/10.3389\/fphar.2012.00014 (2012).","journal-title":"Front. Pharmacol."},{"issue":"1","key":"78751_CR30","doi-asserted-by":"publisher","first-page":"75","DOI":"10.3233\/jad-2001-3111","volume":"3","author":"DJ Selkoe","year":"2001","unstructured":"Selkoe, D. J. Alzheimer\u2019s disease results from the cerebral accumulation and cytotoxicity of amyloid beta-protein. J. Alzheimers Dis. 3(1), 75\u201380. https:\/\/doi.org\/10.3233\/jad-2001-3111 (2001).","journal-title":"J. Alzheimers Dis."},{"issue":"3","key":"78751_CR31","doi-asserted-by":"publisher","first-page":"247","DOI":"10.3233\/jad-2005-8304","volume":"8","author":"EJ Rivera","year":"2005","unstructured":"Rivera, E. J. et al. Insulin and insulin-like growth factor expression and function deteriorate with progression of Alzheimer\u2019s disease: link to brain reductions in acetylcholine. J. Alzheimers Dis. 8(3), 247\u2013268. https:\/\/doi.org\/10.3233\/jad-2005-8304 (2005).","journal-title":"J. Alzheimers Dis."},{"issue":"20","key":"78751_CR32","doi-asserted-by":"publisher","first-page":"12092","DOI":"10.3390\/ijms232012092","volume":"23","author":"V Campos-Pe\u00f1a","year":"2022","unstructured":"Campos-Pe\u00f1a, V. et al. Amyloid \u03b2, lipid metabolism, basal cholinergic system, and therapeutics in Alzheimer\u2019s disease. Int. J. Mol. Sci. 23(20), 12092. https:\/\/doi.org\/10.3390\/ijms232012092 (2022).","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"78751_CR33","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1111\/j.1471-4159.2004.02687.x","volume":"91","author":"D Nonner","year":"2004","unstructured":"Nonner, D., Panickar, K., Barrett, E. F. & Barrett, J. N. Bone morphogenetic proteins and neurotrophins provide complementary protection of septal cholinergic function during phosphatase inhibitor-induced stress. J. Neurochem. 91(1), 77\u201387. https:\/\/doi.org\/10.1111\/j.1471-4159.2004.02687.x (2004).","journal-title":"J. Neurochem."},{"key":"78751_CR34","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.neuroscience.2019.07.035","volume":"439","author":"F Trettel","year":"2020","unstructured":"Trettel, F., Di Castro, M. A. & Limatola, C. Chemokines: key molecules that orchestrate communication among neurons, microglia and astrocytes to preserve brain function. Neuroscience 439, 230\u2013240. https:\/\/doi.org\/10.1016\/j.neuroscience.2019.07.035 (2020).","journal-title":"Neuroscience"},{"issue":"15","key":"78751_CR35","doi-asserted-by":"publisher","first-page":"13244","DOI":"10.1074\/jbc.M300044200","volume":"278","author":"RP Koldamova","year":"2003","unstructured":"Koldamova, R. P. et al. 22R-hydroxycholesterol and 9-cis-retinoic acid induce ATP-binding cassette transporter A1 expression and cholesterol efflux in brain cells and decrease amyloid beta secretion. J. Biol. Chem. 278(15), 13244\u201313256. https:\/\/doi.org\/10.1074\/jbc.M300044200 (2003).","journal-title":"J. Biol. Chem."},{"issue":"6","key":"78751_CR36","doi-asserted-by":"publisher","first-page":"R15","DOI":"10.1172\/JCI6179","volume":"103","author":"DM Holtzman","year":"1999","unstructured":"Holtzman, D. M. et al. Expression of human apolipoprotein E reduces amyloid-beta deposition in a mouse model of Alzheimer\u2019s disease. J. Clin. Investig. 103(6), R15\u2013R21. https:\/\/doi.org\/10.1172\/JCI6179 (1999).","journal-title":"J. Clin. Investig."},{"key":"78751_CR37","doi-asserted-by":"publisher","first-page":"93","DOI":"10.3389\/fnagi.2014.00093","volume":"6","author":"T Kanekiyo","year":"2014","unstructured":"Kanekiyo, T. & Bu, G. The low-density lipoprotein receptor-related protein 1 and amyloid-\u03b2 clearance in Alzheimer\u2019s disease. Front. Aging Neurosci. 6, 93. https:\/\/doi.org\/10.3389\/fnagi.2014.00093 (2014).","journal-title":"Front. Aging Neurosci."},{"issue":"3","key":"78751_CR38","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1093\/brain\/aww349","volume":"140","author":"Z Fan","year":"2017","unstructured":"Fan, Z., Brooks, D. J., Okello, A. & Edison, P. An early and late peak in microglial activation in Alzheimer\u2019s disease trajectory. Brain 140(3), 792\u2013803. https:\/\/doi.org\/10.1093\/brain\/aww349 (2017).","journal-title":"Brain"},{"key":"78751_CR39","doi-asserted-by":"publisher","first-page":"772717","DOI":"10.3389\/fnagi.2021.772717","volume":"13","author":"Q Wang","year":"2021","unstructured":"Wang, Q. et al. Microglia polarization in Alzheimer\u2019s disease: mechanisms and a potential therapeutic target. Front. Aging Neurosci. 13, 772717. https:\/\/doi.org\/10.3389\/fnagi.2021.772717 (2021).","journal-title":"Front. Aging Neurosci."},{"key":"78751_CR40","doi-asserted-by":"publisher","first-page":"198","DOI":"10.3389\/fncel.2020.00198","volume":"14","author":"AM Jurga","year":"2020","unstructured":"Jurga, A. M., Paleczna, M. & Kuter, K. Z. Overview of general and discriminating markers of differential microglia phenotypes. Front. Cell. Neurosci. 14, 198. https:\/\/doi.org\/10.3389\/fncel.2020.00198 (2020).","journal-title":"Front. Cell. Neurosci."},{"issue":"5","key":"78751_CR41","doi-asserted-by":"publisher","first-page":"2241","DOI":"10.4049\/jimmunol.1200947","volume":"190","author":"TC Browne","year":"2013","unstructured":"Browne, T. C. et al. IFN-\u03b3 production by amyloid \u03b2-specific Th1 cells promotes microglial activation and increases plaque burden in a mouse model of Alzheimer\u2019s disease. J. Immunol. 190(5), 2241\u20132251. https:\/\/doi.org\/10.4049\/jimmunol.1200947 (2013).","journal-title":"J. Immunol."},{"issue":"1","key":"78751_CR42","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1172\/JCI88647","volume":"127","author":"RA Taylor","year":"2017","unstructured":"Taylor, R. A. et al. TGF-\u03b21 modulates microglial phenotype and promotes recovery after intracerebral hemorrhage. J. Clin. Investig. 127(1), 280\u2013292. https:\/\/doi.org\/10.1172\/JCI88647 (2017).","journal-title":"J. Clin. Investig."},{"key":"78751_CR43","doi-asserted-by":"publisher","first-page":"2750","DOI":"10.3389\/fimmu.2018.02750","volume":"9","author":"F Lepore","year":"2018","unstructured":"Lepore, F. et al. CXCL16\/CXCR6 axis drives microglia\/macrophages phenotype in physiological conditions and plays a crucial role in glioma. Front. Immunol. 9, 2750. https:\/\/doi.org\/10.3389\/fimmu.2018.02750 (2018).","journal-title":"Front. Immunol."},{"issue":"2","key":"78751_CR44","doi-asserted-by":"publisher","first-page":"459","DOI":"10.3233\/JAD-140036","volume":"42","author":"TV Nguyen","year":"2014","unstructured":"Nguyen, T. V. et al. Small molecule p75NTR ligands reduce pathological phosphorylation and misfolding of tau, inflammatory changes, cholinergic degeneration, and cognitive deficits in A\u03b2PP(L\/S) transgenic mice. J. Alzheimers Dis. 42(2), 459\u2013483. https:\/\/doi.org\/10.3233\/JAD-140036 (2014).","journal-title":"J. Alzheimers Dis."},{"issue":"3","key":"78751_CR45","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1007\/s12035-014-8825-3","volume":"51","author":"YZ Guan","year":"2015","unstructured":"Guan, Y. Z. et al. Nicotine inhibits microglial proliferation and is neuroprotective in global ischemia rats. Mol. Neurobiol. 51(3), 1480\u20131488. https:\/\/doi.org\/10.1007\/s12035-014-8825-3 (2015).","journal-title":"Mol. Neurobiol."},{"key":"78751_CR46","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.2147\/JPR.S159146","volume":"11","author":"Q Liu","year":"2018","unstructured":"Liu, Q. et al. \u03b17 nicotinic acetylcholine receptor-mediated anti-inflammatory effect in a chronic migraine rat model via the attenuation of glial cell activation. J. Pain Res. 11, 1129\u20131140. https:\/\/doi.org\/10.2147\/JPR.S159146 (2018).","journal-title":"J. Pain Res."},{"key":"78751_CR47","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1152\/physrev.1996.76.3.651","volume":"76","author":"DA Jans","year":"1996","unstructured":"Jans, D. A. & H\u00fcbner, S. Regulation of protein transport to the nucleus: central role of phosphorylation. Physiol. Rev. 76, 651\u2013685. https:\/\/doi.org\/10.1152\/physrev.1996.76.3.651 (1996).","journal-title":"Physiol. Rev."},{"key":"78751_CR48","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1042\/0264-6021:3490141","volume":"349","author":"T Dobransky","year":"2000","unstructured":"Dobransky, T., Davis, W. L., Xiao, G. H. & Rylett, R. J. Expression, purification and characterization of recombinant human choline acetyltransferase: phosphorylation of the enzyme regulates catalytic activity. Biochem. J. 349, 141\u2013151. https:\/\/doi.org\/10.1042\/0264-6021:3490141 (2000).","journal-title":"Biochem. J."},{"key":"78751_CR49","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.bbr.2017.11.017","volume":"364","author":"A Latif-Hernandez","year":"2019","unstructured":"Latif-Hernandez, A. et al. Subtle behavioral changes and increased prefrontal-hippocampal network synchronicity in APPNL-G-F mice before prominent plaque deposition. Behav. Brain. Res. 364, 431\u2013441. https:\/\/doi.org\/10.1016\/j.bbr.2017.11.017 (2019).","journal-title":"Behav. Brain. Res."},{"key":"78751_CR50","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.bbr.2017.09.006","volume":"336","author":"LS Whyte","year":"2018","unstructured":"Whyte, L. S. et al. Reduction in open field activity in the absence of memory deficits in the AppNL-G-F knock-in mouse model of Alzheimer\u2019s disease. Behav. Brain. Res. 336, 177\u2013181. https:\/\/doi.org\/10.1016\/j.bbr.2017.09.006 (2018).","journal-title":"Behav. Brain. Res."},{"key":"78751_CR51","doi-asserted-by":"publisher","first-page":"909989","DOI":"10.3389\/fnmol.2022.909989","volume":"15","author":"S Wang","year":"2022","unstructured":"Wang, S. et al. Age-dependent behavioral and metabolic assessment of AppNL-G-F\/NL-G-F knock-in (KI) mice. Front. Mol. Neurosci. 15, 909989. https:\/\/doi.org\/10.3389\/fnmol.2022.909989 (2022).","journal-title":"Front. Mol. Neurosci."},{"key":"78751_CR52","doi-asserted-by":"publisher","first-page":"113192","DOI":"10.1016\/j.bbr.2021.113192","volume":"404","author":"A Locci","year":"2021","unstructured":"Locci, A. et al. Comparison of memory, affective behavior, and neuropathology in APPNLGF knock-in mice to 5xFAD and APP\/PS1 mice. Behav. Brain. Res. 404, 113192. https:\/\/doi.org\/10.1016\/j.bbr.2021.113192 (2021).","journal-title":"Behav. Brain. Res."},{"key":"78751_CR53","doi-asserted-by":"publisher","unstructured":"Pervolaraki, E. et al. Insoluble A\u03b2 overexpression in an app knock-in mouse model alters microstructure and gamma oscillations in the prefrontal cortex, affecting anxiety-related behaviours. Dis. Models Mech. Int. J. Dev. Neurosci. 1221(97), 040550. https:\/\/doi.org\/10.1242\/dmm.040550 (20192003).","DOI":"10.1242\/dmm.040550"},{"key":"78751_CR54","doi-asserted-by":"publisher","unstructured":"Klingner, M. et al. Alterations in cholinergic and non-cholinergic neurotransmitter receptor densities in transgenic Tg2576 mouse brain with beta-amyloid plaque pathology. Int. J.Dev. Neurosci. 21(7), 357\u2013369. https:\/\/doi.org\/10.1016\/j.ijdevneu.2003.08.001 (2003).","DOI":"10.1016\/j.ijdevneu.2003.08.001"},{"key":"78751_CR55","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.neurobiolaging.2018.10.026","volume":"75","author":"J Mehla","year":"2019","unstructured":"Mehla, J. et al. Age-dependent behavioral and biochemical characterization of single APP knock-in mouse (APPNL-G-F\/NL-G-F) model of Alzheimer\u2019s disease. Neurobiol. Aging 75, 25\u201337. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2018.10.026 (2019).","journal-title":"Neurobiol. Aging"},{"issue":"11","key":"78751_CR56","doi-asserted-by":"publisher","first-page":"3248","DOI":"10.3390\/nu12113248","volume":"12","author":"H Nieraad","year":"2020","unstructured":"Nieraad, H. et al. Impact of hyperhomocysteinemia and different dietary interventions on cognitive performance in a knock-in mouse model for Alzheimer\u2019s disease. Nutrients 12(11), 3248. https:\/\/doi.org\/10.3390\/nu12113248 (2020).","journal-title":"Nutrients"},{"issue":"1","key":"78751_CR57","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s12868-018-0446-8","volume":"19","author":"Y Sakakibara","year":"2018","unstructured":"Sakakibara, Y., Sekiya, M., Saito, T., Saido, T. C. & Iijima, K. M. Cognitive and emotional alterations in app knock-in mouse models of A\u03b2 amyloidosis. BMC Neurosci. 19(1), 46. https:\/\/doi.org\/10.1186\/s12868-018-0446-8 (2018).","journal-title":"BMC Neurosci."},{"issue":"1","key":"78751_CR58","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.bbr.2008.12.034","volume":"200","author":"G Taglialatela","year":"2009","unstructured":"Taglialatela, G., Hogan, D., Zhang, W. R. & Dineley, K. T. Intermediate- and long-term recognition memory deficits in Tg2576 mice are reversed with acute calcineurin inhibition. Behav. Brain. Res. 200(1), 95\u201399. https:\/\/doi.org\/10.1016\/j.bbr.2008.12.034 (2009).","journal-title":"Behav. Brain. Res."},{"issue":"1\u20132","key":"78751_CR59","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/s0006-8993(00)03186-3","volume":"891","author":"GW Arendash","year":"2001","unstructured":"Arendash, G. W. et al. Progressive, age-related behavioral impairments in transgenic mice carrying both mutant amyloid precursor protein and presenilin-1 transgenes. Brain Res. 891(1\u20132), 42\u201353. https:\/\/doi.org\/10.1016\/s0006-8993(00)03186-3 (2001).","journal-title":"Brain Res."},{"key":"78751_CR60","doi-asserted-by":"publisher","first-page":"37","DOI":"10.2147\/CLEP.S37929","volume":"6","author":"MM Mielke","year":"2014","unstructured":"Mielke, M. M., Vemuri, P. & Rocca, W. A. Clinical epidemiology of Alzheimer\u2019s disease: assessing sex and gender differences. Clin. Epidemiol. 6, 37\u201348. https:\/\/doi.org\/10.2147\/CLEP.S37929 (2014).","journal-title":"Clin. Epidemiol."},{"issue":"4","key":"78751_CR61","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.bcp.2014.01.011","volume":"88","author":"D Puzzo","year":"2014","unstructured":"Puzzo, D., Lee, L., Palmeri, A., Calabrese, G. & Arancio, O. Behavioral assays with mouse models of Alzheimer\u2019s disease: practical considerations and guidelines. Biochem. Pharmacol. 88(4), 450\u2013467. https:\/\/doi.org\/10.1016\/j.bcp.2014.01.011 (2014).","journal-title":"Biochem. Pharmacol."},{"key":"78751_CR62","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.neuint.2004.11.006","volume":"46","author":"A Matsuo","year":"2005","unstructured":"Matsuo, A. et al. Rat choline acetyltransferase of the peripheral type differs from that of the common type in intracellular translocation. Neurochem. Int. 46, 423\u2013433. https:\/\/doi.org\/10.1016\/j.neuint.2004.11.006 (2005).","journal-title":"Neurochem. Int."},{"issue":"1","key":"78751_CR63","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s13024-021-00489-6","volume":"16","author":"A Iatrou","year":"2021","unstructured":"Iatrou, A., Clark, E. M. & Wang, Y. Nuclear dynamics and stress responses in Alzheimer\u2019s disease. Mol. Neurodegener. 16(1), 65. https:\/\/doi.org\/10.1186\/s13024-021-00489-6 (2021).","journal-title":"Mol. Neurodegeneration"},{"issue":"1","key":"78751_CR64","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1097\/nen.0b013e31802d6da9","volume":"66","author":"CP Ramsey","year":"2007","unstructured":"Ramsey, C. P. et al. Expression of Nrf2 in neurodegenerative diseases. J. Neuropathol. Exp. Neurol. 66(1), 75\u201385. https:\/\/doi.org\/10.1097\/nen.0b013e31802d6da9 (2007).","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"1","key":"78751_CR65","doi-asserted-by":"publisher","first-page":"e53349","DOI":"10.1371\/journal.pone.0053349","volume":"8","author":"D Mastroeni","year":"2013","unstructured":"Mastroeni, D. et al. Reduced RAN expression and disrupted transport between cytoplasm and nucleus; a key event in Alzheimer\u2019s disease pathophysiology. PLoS ONE 8(1), e53349. https:\/\/doi.org\/10.1371\/journal.pone.0053349 (2013).","journal-title":"PLoS ONE"},{"issue":"2","key":"78751_CR66","doi-asserted-by":"publisher","first-page":"775","DOI":"10.3233\/JAD-160926","volume":"56","author":"C Brandscheid","year":"2017","unstructured":"Brandscheid, C. et al. Altered gut microbiome composition and tryptic activity of the 5xFAD Alzheimer\u2019s mouse model. J. Alzheimers Dis. 56(2), 775\u2013788. https:\/\/doi.org\/10.3233\/JAD-160926 (2017).","journal-title":"J. Alzheimers Dis."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-78751-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-78751-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-78751-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,11]],"date-time":"2024-11-11T17:08:19Z","timestamp":1731344899000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-78751-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,11]]},"references-count":66,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["78751"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-78751-2","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,11]]},"assertion":[{"value":"9 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"27614"}}